An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Novanta to Present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference on Wednesday, January 12, 2022
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Novanta Inc. (NASDAQ: NOVT) announced that Chief Financial Officer Robert Buckley and Executive Vice President Charlie Webster will present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference on Wednesday, January 12, 2022. Novanta is a leading global supplier of technology solutions for medical and advanced industrial OEMs, focusing on photonics, vision, and precision motion. The company's innovative team drives its success by addressing complex technical challenges, enhancing performance and precision in applications.
Positive
None.
Negative
None.
BEDFORD, Mass.--(BUSINESS WIRE)--
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Charlie Webster, Executive Vice President, are scheduled to present at the CJS Securities 22nd Annual New Ideas for the New Year Investor Conference, which is being held virtually, on Wednesday, January 12, 2022.
About Novanta
Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers (“OEMs”) a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers’ demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta’s common shares are quoted on Nasdaq under the ticker symbol “NOVT”.
More information about Novanta is available on the Company’s website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or InvestorRelations@novanta.com.